Inhibitory, Monoclonal antibody against blood clotting factor VII-activating protease

Details for Australian Patent Application No. 2003200420 (hide)

Owner CSL Behring GmbH

Inventors Nakazawa, Fumie; Feussner, Annette; Lang, Wiegand; Kannemaier, Christian; Stoehr, Hans-Arnold; Preissner, Klaus; Muthnaumann, Gudrun; Roemisch, Juergen

Agent Watermark

Pub. Number AU-B-2003200420

Priority 10205520.3 08.02.02 DE

Filing date 7 February 2003

Wipo publication date 28 August 2003

Acceptance publication date 28 January 2010

International Classifications

G01N 33/573 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for enzymes or isoenzymes

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61P 7/02 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 17/02 (2006.01) Drugs for dermatological disorders

A61P 35/00 (2006.01) Antineoplastic agents

C07K 16/40 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against enzymes

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 5/20 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - one of the fusion partners being a B lymphocyte

C12N 9/64 (2006.01) Enzymes, e.g. ligases (6.) - derived from animal tissue, e.g. rennin

C12N 9/99 (2006.01) Enzymes, e.g. ligases (6.) - Enzyme inactivation by chemical treatment

C12P 21/08 (2006.01) Preparation of peptides or proteins - Monoclonal antibodies

C12Q 1/37 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving peptidase or proteinase

G01N 33/577 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving monoclonal antibodies

G01N 33/86 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving blood coagulating time

Event Publications

20 February 2003 Complete Application Filed

  Priority application(s): 10205520.3 08.02.02 DE

28 August 2003 Application Open to Public Inspection

  Published as AU-B-2003200420

17 March 2005 Change of Name(s) of Applicant(s), Section 104

  Aventis Behring GmbH The name of the applicant has been changed to ZLB Behring GmbH

23 August 2007 Change of Name(s) of Applicant(s), Section 104

  ZLB Behring GmbH The name of the applicant has been changed to CSL Behring GmbH

28 January 2010 Application Accepted

  Published as AU-B-2003200420

27 May 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003200421-Enantiomerically pure betaD-dioxolane-nucleosides

2003200419-Gaming Device Having a Pick Reduction Game